openPR Logo
Press release

Circulating Biomarkers Market Analysis by Segments, Size, Share and Forecast 2020

09-06-2017 11:35 AM CET | Health & Medicine

Press release from: TMR - Healthcare

Circulating Biomarkers Market Analysis by Segments, Size,

Global Circulating Biomarkers Market: Overview

Tumor cells when dying, release small pieces of their DNA into the bloodstream and these strands are known as cell-free circulating biomarkers. These biomarkers are becoming the part and parcel of healthcare management owing to their application in monitoring progression of a disease, performing a biopsy, and deciding a treatment regimen. They are used for therapeutics and diagnosis of broad array of specialties such as cardiovascular, immunology, neurology, cancer, and metabolic diseases.

The report on the global circulating biomarkers market serves as a reliable business tool providing information regarding several important parameters of the market including its dynamics, regional outlook, and vendor landscape. It analyzes the business strategies, latest developments, and cost and revenue structure of key players in the market and profiles them. A separate section of recommendations is presented in the report for both existing and new players in the market. It takes into consideration historic as well as current scenario to forecast the future trends of the global circulating biomarkers market.

Obtain Report Details @
http://www.transparencymarketresearch.com/circulating-biomarkers-market.html

Global Circulating Biomarkers Market: Drivers and Restraints

The rising prevalence of cancer is the foremost factor augmenting the global circulating biomarkers market. Circulating biomarkers can be effectively applied to every stage of cancer patient care. It can be used as a reliable screening method as circulating tumor DNA (ctDNA) is detected at both early and advanced stages in the majority of cancer types.

The growing awareness regarding their merits, thanks to government initiatives and conferences, is providing a fillip to the market. These biomarkers are instrumental in informing treatment decision and revolutionizing personalized medicine. The Food and Drug Administration (FDA) estimates that an improvement of 10% in the ability to calculate drug failures before clinical trials can save up to US$100 mn in costs of development per drug. The increasing funding from public and private organizations for the development of these biomarkers is also working in favor of the market. On the other hand, the lack of clear regulatory and reimbursement scenario is hampering the growth of the global circulating biomarkers market.

Global Circulating Biomarkers Market: Regional Outlook

The key segments analyzed in the report on the basis of geography are Asia Pacific, North America, Europe, and Rest of the World. North America is anticipated to account for a substantial share in the revenue pie of the global market. The increasing prevalence of cancer in this region is translating into the greater uptake of biomarkers for drug delivery as well as cancer treatment. A report by the American Cancer Society indicates that there were nearly 1,685,210 new cancer cases diagnosed and 595,690 cancer deaths in the U.S. in 2016. Moreover, the growing adoption of targeted therapies for treating patients with chronic diseases are driving the growth of the region.

Asia Pacific is expected to register noteworthy CAGR during the review period. The development of personalized medicine and more-targeted therapies is gaining significant momentum, which turn is propelling the growth of the region. The growth of this region can also be attributed to the advancements in sequencing technology and expanding population base in countries such as India, China, and Vietnam.

Global Circulating Biomarkers Market: Competitive Landscape

The strong foothold of pharmaceutical giants renders the global circulating biomarkers market highly competitive. Some of the key players in the market are Affymetrix Inc., Abbott Laboratories, Agilent Technologies Inc., Becton, Dickson and Company, Biocept Inc., Epigenomics AG, and GE Healthcare. The high financial and technological capabilities of these players are creating high entry barrier for new players interested in venturing into this market. Many players are adopting strategic mergers and acquisitions as key strategies to strengthen their position in the market.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3850

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Circulating Biomarkers Market Analysis by Segments, Size, Share and Forecast 2020 here

News-ID: 700191 • Views:

More Releases from TMR - Healthcare

Clinical Trial Management System (CTMS) Market : Projection of Each Major Segment over the Forecast Period
Clinical Trial Management System (CTMS) Market : Projection of Each Major Segmen …
With companies long having realized that the best way to remain competitive in the pharmaceutical industry is by ploughing back of profits into R&D projects, the demand for clinical trial management systems is expected to see an uptick. While this will help impel the market greatly in the coming years, what also needs to be taken into consideration that the cost of implementing such a system may deter investment decisions. The
Electronic Health Records Market : Industry Analysis and Detailed Profiles of to …
The global market for electronic health record (EHR) features a largely fragmented vendor landscape, with the presence of a large number of small and large players and the top five companies cumulatively accounting for a nearly 44% of the overall market in 2016. Leading vendors in the global EHR market are adopting inorganic growth strategies such as mergers and acquisitions to expand their reach across high-growth potential regional markets, consolidate
Fuel Oil Market Intelligence Report Offers Growth Prospects
Fuel Oil Market Intelligence Report Offers Growth Prospects
The global transportation industry has been growing at a significant pace since the past decade. Companies operating in the transportation industry are the largest consumers of the fuel oil. Apart from this, fuel oil also finds application in the petrochemical industry and petroleum refineries. The building materials industry is also on the rise since many years. The demand for fuel oil is expected to increase from the building materials industry.
Thermoset Resin Market Global Industry Analysis, Trends and Forecast, 2016 - 2024
Thermoset Resin Market Global Industry Analysis, Trends and Forecast, 2016 - 202 …
The global composite industry has been expanding significantly in terms of production, technological advancements, and developments. Thermoset resin plays a vital role in the composite industry. Thermoset resins are used extensively in the manufacture of composites; these resins are employed in the fabrication of products for end-use industries such as aerospace, automotive, sporting goods, construction, electronics, and wind energy. The thermoset resin market can be segmented into six resin types:

All 5 Releases


More Releases for Circulating

Circulating Tumour DNA Market Size Report 2034
On April 25, 2025, Exactitude Consultancy., Ltd. released a research report titled "Circulating Tumour DNA Market". This report covers the global Circulating Tumor DNA market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends.
Key Trend Reshaping the Circulating Fluid Bed Boilers Market in 2025: Strategic …
What combination of drivers is leading to accelerated growth in the circulating fluid bed boilers market? The circulating fluid bed boiler market is predicted to expand due to a surge in coal consumption. Coal, a black rock extracted from the earth, is used as fuel. These boilers are typically found in coal-fired power plants, where they create steam to run large turbines, and the mineral components of coal are converted into
Circulating Water Baths Market Size 2024 to 2031.
Market Overview and Report Coverage A circulating water bath is a laboratory device used to heat or cool samples in a controlled environment. These baths are essential equipment in various industries such as healthcare, pharmaceuticals, and research labs for conducting experiments that require precise temperature control. The circulating water baths market is expected to witness significant growth in the coming years, with a projected CAGR of 5.00% during the forecasted
Circulating Tumor Cells Market 2023 | Detailed Report
The Circulating Tumor Cells report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research. The Circulating Tumor Cells research report recognizes and
Global Circulating Cell-Free DNA Diagnostics Market
According to a new market research report published by Global Market Estimates, the Global Circulating Cell-Free DNA (ccfDNA) Diagnostics Market is projected to grow from USD 4.9 billion in 2022 to USD 13.1 billion in 2027 at a CAGR of 21.7% from 2022 to 2027. Hoffmann-La Roche, Natera Inc., Illumina Inc., Agena Bioscience, Paragon Genomics, Thermo Fisher Scientific, Bio-Rad Laboratories, Lucence Health, and Eurofins among others are some key players in
Global Circulating Thermostats Market Analysis by 2020-2025
Scope of the Report: The global Circulating Thermostats market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. Market segmentation Circulating Thermostats market is split by Type and by Application. For the period 2015-2025, the growth among segments